Caris Life Sciences (CAI) Change in Inventory (2024 - 2026)

Caris Life Sciences' Change in Inventory history runs 3 years deep, the most recent figure standing at $13.3 million for Q1 2026.

• On a quarterly basis, Change in Inventory rose 746.68% year-over-year to $13.3 million in Q1 2026; TTM through Mar 2026 was $36.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $20.8 million, up 480.11% from the prior year.
• Change in Inventory grew to $13.3 million in Q1 2026 per CAI's latest filing, from $9.6 million in the prior quarter.
• Across five years, Change in Inventory topped out at $13.3 million in Q1 2026 and bottomed at -$2.1 million in Q1 2025.
• The 3-year median for Change in Inventory is $4.7 million (2025), against an average of $5.2 million.
• Biggest YoY gain for Change in Inventory was 869.71% in 2025; the steepest drop was 158.82% in 2025.
• Year by year, Change in Inventory stood at -$1.2 million in 2024, then jumped by 869.71% to $9.6 million in 2025, then surged by 38.75% to $13.3 million in 2026.
• Per Business Quant, the three latest CAI Change in Inventory figures stand at $13.3 million (Q1 2026), $9.6 million (Q4 2025), and $8.5 million (Q3 2025).